documents: FDA-2015-N-3326-0056

Federal regulatory documents currently open for public comment. ⚠ Derive comment deadlines from comment_end_datetime converted to America/New_York, never from comment_end_date, which is mid-correction and may be one day late (DataDawn queue #498).

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	agency_id	docket_id	title	document_type	subtype	posted_date	posted_year	posted_month	comment_start_date	comment_end_date	comment_end_datetime	perpetual_docket	last_modified	fr_doc_num	open_for_comment	withdrawn	object_id
FDA-2015-N-3326-0056	FDA	FDA-2015-N-3326	Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for Comments	Notice	Request for Comments	2026-09-25	2026	9	2026-09-25	2026-11-25	2026-11-26 04:59:59	0	2026-10-06 09:00:35	2026-19660	1	0	09000064b95c53b7